Cardio-Renal Syndrome - 24 Studies Found

Completed : Contrast-induced Nephropathy: Incidence,Risk Factors,Effective Prevention and Management Method
: Cardio-Renal Syndrome
: 2016-01-22
: Device: percutaneous coronary intervention
Completed : Central Venous Pressure Guided Hydration Prevention for Contrast-Induced Nephropathy
: Cardio-Renal Syndrome
: 2015-03-23
:
  • Procedure: hydration Before th
Enrolling by invitation : Levosimendan Versus Dobutamine for Renal Function in Heart Failure
: Cardiorenal Syndrome
: 2014-05-05
:
  • Drug: Levosimendan Other Name:
Recruiting : CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function
: Cardiorenal Syndrome (CRS)
: 2012-08-31
:
  • Drug: Candesartan 4 mg once a

Active, not recruiting : The Role of CVP in Patients With Cardio-renal Syndromes
: Heart Failure
: 2016-05-16
: Other: CVP measurement CVP measurements had been performed with an electronic pressure transducer in spo
Active, not recruiting : Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU)
:
  • Chronic Kidney Disease
  • Acute Heart Failure

: 2010-09-29
Active, not recruiting : Cardiorenal Syndrome in End-Stage Kidney Disease
:
  • End-stage Renal Disease
  • Cardiorenal Syndrome
  • Chronic Heart Failure
  • Cardio-Renal Syndrome

: 2014-03-10
: Device: Renal denervation (Symplicity™) Delivery of radiofrequency through the wall of the renal a
Terminated : Nesiritide and Renal Function After the Total Artificial Heart
:
  • Congestive Heart Failure
  • Cardiorenal Syndrome

: 2013-04-17
:
  • Drug: nesiritide nesiritide at
Completed : Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome
:
  • Heart Failure, Congestive
  • Renal Insufficiency, Chronic

: 2006-07-25
: Drug: Erythropoietin administration 50 IU/kg/week EPO to a target haemoglobin level of 13.7 g/dL for men
<<< Previous | Next >>>